Elo Mutual Pension Insurance Co Boosts BioMarin Pharmaceutical Holdings

The institutional investor increased its stake in the biotech company by over 97% in the third quarter.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Elo Mutual Pension Insurance Co grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 97.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor now owns 46,380 shares of the biotechnology company's stock, valued at $2.51 million.

Why it matters

BioMarin Pharmaceutical is a leading biopharmaceutical company focused on developing and commercializing therapies for rare genetic and metabolic diseases. The significant increase in Elo Mutual Pension Insurance Co's holdings suggests the investor sees strong potential in the company's pipeline and commercial products.

The details

Elo Mutual Pension Insurance Co added 22,851 shares to its BioMarin Pharmaceutical position during the third quarter, bringing its total holdings to 46,380 shares. The company's stock closed at $58.53 on Wednesday, March 4, 2026, giving the Elo Mutual Pension Insurance Co's stake a market value of $2.51 million.

Elo Mutual Pension Insurance Co increased its BioMarin Pharmaceutical holdings in the third quarter of 2025.
BioMarin Pharmaceutical's stock closed at $58.53 on Wednesday, March 4, 2026.

The players